Mansoori, S.
Fryknäs, M.
Alvfors, C.
Loskog, A.
Larsson, R.
Nygren, P.
Funding for this research was provided by:
cancer fonden
Uppsala University
Article History
Received: 17 November 2020
Accepted: 12 April 2021
First Online: 26 April 2021
Competing interests
: MF, RL and PN are co-founders of Repos Pharma AB and AL is its chairman of the board. SM and CA declares no conflict of interest.